MYC and head and neck squamous cell carcinoma: Unexpectedly, although the oncogene MYC has been extensively reported to be a critical target of BET inhibition in various malignancies, it was only mildly inhibited by JQ1 in HNSCC cells (Supplementary Fig. 1a).